Deanfield, John

Ventricular arrhythmia in unrepaired and repaired tetralogy of Fallot: relation to age, timing of repair, and haemodynamic status

Deanfield, J. E., McKenna, W. J., Presbitero, P., England, D., Graham, G. R., & Hallidie-Smith, K. (1984) · Heart

Congenital Heart Disease StudiesCardiac Arrhythmias and Treatments

Cited by 158

Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial

Deanfield, J., Lincoff, A. M., Kahn, S. E., Emerson, S. S., Lingvay, I., Scirica, B. M., Plutzky, J., Kushner, R. F., Colhoun, H. M., Hovingh, G. K., et al. (2025) · The Lancet

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 143

Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL , a randomized trial

McGuire, D. K., Busui, R. P., Deanfield, J., Inzucchi, S. E., Mann, J. F. E., Marx, N., Mulvagh, S. L., Poulter, N., Engelmann, M. D. M., Hovingh, G. K., et al. (2023) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 131

Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses

Kosiborod, M. N., Bhatta, M., Davies, M., Deanfield, J. E., Garvey, W. T., Khalid, U., Kushner, R., Rubino, D. M., Zeuthen, N., & Verma, S. (2023) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 127

Excess mortality in england and wales during the first wave of the COVID-19 pandemic

Kontopantelis, E., Mamas, M. A., Deanfield, J., Asaria, M., & Doran, T. (2021) · Journal of Epidemiology and Community Health

COVID-19 epidemiological studiesCOVID-19 and healthcare impacts

Cited by 121

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

Lingvay, I., Brown‐Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt‐Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · Obesity

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 113

ACE inhibitors and statins in adolescents with type 1 diabetes

Marcovecchio, M. L., Chiesa, S. T., Bond, S., Daneman, D., Dawson, S., Donaghue, K. C., Jones, T. W., Mahmud, F. H., Marshall, S. M., Neil, H. A. W., et al. (2017) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesDiabetes Management and Research

Cited by 112

Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials

Verma, S., Bhatta, M., Davies, M., Deanfield, J. E., Garvey, W. T., Jensen, C., Kandler, K., Kushner, R. F., Rubino, D. M., & Kosiborod, M. N. (2023) · eClinicalMedicine

Adipokines, Inflammation, and Metabolic DiseasesPharmacology and Obesity Treatment

Cited by 106

The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Design of a randomized clinical trial, baseline data and implications for a long-term outcome trial

Pepine, C. J., Geller, N. L., Knatterud, G. L., Bourassa, M. G., Chaitman, B. R., Davies, R. F., Day, P., Deanfield, J. E., Goldberg, A. D., McMahon, R. P., et al. (1994) · Journal of the American College of Cardiology

Heart rate and cardiovascular healthCoronary Interventions and Diagnostics

Cited by 105

Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms

Sofat, R., Hingorani, A. D., Smeeth, L., Humphries, S. E., Talmud, P. J., Cooper, J., Shah, T., Sandhu, M. S., Ricketts, S. L., Boekholdt, S. M., et al. (2010) · Circulation

Lipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

Cited by 104

Adipose and Height Growth Through Childhood and Blood Pressure Status in a Large Prospective Cohort Study

Jones, A., Charakida, M., Falaschetti, E., Hingorani, A. D., Finer, N., Masi, S., Donald, A. E., Lawlor, D. A., Davey Smith, G., & Deanfield, J. E. (2012) · Hypertension

Birth, Development, and HealthBlood Pressure and Hypertension Studies

Cited by 93

Oral semaglutide and cardiovascular outcomes in people with type 2 diabetes, according to SGLT2i use: prespecified analyses of the SOUL randomized trial

Marx, N., Deanfield, J. E., Mann, J. F. E., Arechavaleta, R., Bain, S. C., Bajaj, H. S., Bayer Tanggaard, K., Birkenfeld, A. L., Buse, J. B., Davicevic-Elez, Z., et al. (2025) · Circulation

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 70

The Blackfriars consensus on brain health and dementia

Lincoln, P., Fenton, K., Alessi, C., Prince, M., Brayne, C., Wortmann, M., Patel, K., Deanfield, J., & Mwatsama, M. (2014) · The Lancet

Dementia and Cognitive Impairment ResearchDown syndrome and intellectual disability research

Cited by 69

Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials

Lee, M. M. Y., Sattar, N., Pop-Busui, R., Deanfield, J., Emerson, S. S., Inzucchi, S. E., Mann, J. F. E., Marx, N., Mulvagh, S. L., Poulter, N. R., et al. (2025) · Diabetes Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 63

Elevated high-density lipoprotein in adolescents with type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation

Chiesa, S. T., Charakida, M., McLoughlin, E., Nguyen, H. C., Georgiopoulos, G., Motran, L., Elia, Y., Marcovecchio, M. L., Dunger, D. B., Dalton, R. N., et al. (2019) · European Heart Journal

Diabetes, Cardiovascular Risks, and LipoproteinsNitric Oxide and Endothelin Effects

Cited by 54

The Effect of Semaglutide on Mortality and COVID-19–Related Deaths

Scirica, B. M., Lincoff, A. M., Lingvay, I., Bogdanski, P., Buscemi, S., Colhoun, H., Craciun, A.-E., Ezhov, M., Hardt-Lindberg, S., Kleist Jeppesen, O., et al. (2024) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 51

Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study

Alabas, O. A., Hall, M., Dondo, T. B., Rutherford, M. J., Timmis, A. D., Batin, P. D., Deanfield, J. E., Hemingway, H., & Gale, C. P. (2017) · Journal of Epidemiology and Community Health

Acute Myocardial Infarction ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 51

Association between resting heart rate across the life course and all-cause mortality: Longitudinal findings from the Medical Research Council (MRC) National Survey of Health and Development (NSHD)

Ó Hartaigh, B., Gill, T. M., Shah, I., Hughes, A. D., Deanfield, J. E., Kuh, D., & Hardy, R. (2014) · Journal of Epidemiology and Community Health

Heart Rate Variability and Autonomic ControlHeart rate and cardiovascular health

Cited by 40

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial

Kushner, R. F., Ryan, D. H., Deanfield, J., Kokkinos, A., Cercato, C., Wilding, J., Burguera, B., Wu, C., Craciun, A., Pall, D., et al. (2025) · Obesity

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 35

Systems Analysis Implicates WAVE2 Complex in the Pathogenesis of Developmental Left-Sided Obstructive Heart Defects

Edwards, J. J., Rouillard, A. D., Fernandez, N. F., Wang, Z., Lachmann, A., Shankaran, S. S., Bisgrove, B. W., Demarest, B., Turan, N., Srivastava, D., et al. (2020) · JACC: Basic to Translational Science

Congenital heart defects researchCardiomyopathy and Myosin Studies

Cited by 27

Impact of intentional weight loss in cardiometabolic disease: what we know about timing of benefits on differing outcomes?

Sattar, N., Deanfield, J., & Delles, C. (2024) · Cardiovascular Research

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Disease and Adiposity

Cited by 20

Submaximal exercise blood pressure and cardiovascular structure in adolescence

Schultz, M. G., Park, C., Fraser, A., Howe, L. D., Jones, S., Rapala, A., Davey Smith, G., Sharman, J. E., Lawlor, D. A., Chaturvedi, N., et al. (2019) · International Journal of Cardiology

Cardiovascular Health and Disease PreventionCardiovascular and exercise physiology

Cited by 15

Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the SELECT trial

Plutzky, J., Bogdański, P., Dagdelen, S., Deanfield, J., Emerson, S., Hovingh, G., Kahn, S., Larsen, S., Latkovskis, G., Lehrke, M., et al. (2024) · Atherosclerosis

Adipokines, Inflammation, and Metabolic DiseasesDiabetes Treatment and Management

Cited by 2